AA
TMO icon

Addison Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Addison Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$120K Sell
240
-74
-24% -$35.5K 0.06% 162
2026
Q1 		$154K Buy
314
+7
+2% +$3.8K 0.03% 258
2025
Q4 		$178K Sell
307
-1
-0.3% -$566 0.04% 232
2025
Q3 		$149K Buy
308
+12
+4% +$5.59K 0.03% 259
2025
Q2 		$120K Sell
296
-9
-3% -$3.76K 0.03% 278
2025
Q1 		$152K Buy
305
+17
+6% +$9.21K 0.04% 244
2024
Q4 		$150K Sell
288
-30
-9% -$16.5K 0.04% 243
2024
Q3 		$197K Buy
318
+18
+6% +$10.7K 0.05% 217
2024
Q2 		$166K Buy
300
+24
+9% +$13.7K 0.05% 224
2024
Q1 		$160K Buy
276
+45
+19% +$25.3K 0.06% 223
2023
Q4 		$123K Buy
231
+48
+26% +$23.2K 0.05% 250
2023
Q3 		$92.6K Buy
183
+82
+81% +$43.7K 0.04% 257
2023
Q2 		$52.7K Sell
101
-14
-12% -$7.55K 0.03% 313
2023
Q1 		$66.3K Buy
115
+4
+4% +$2.25K 0.04% 270
2022
Q4 		$61.1K Buy
111
+43
+63% +$22.8K 0.04% 269
2022
Q3 		$34K Buy
68
+12
+21% +$6.72K 0.02% 296
2022
Q2 		$30K Sell
56
-29
-34% -$16K 0.02% 322
2022
Q1 		$50K Buy
85
+52
+158% +$29.9K 0.03% 287
2021
Q4 		$22K Buy
33
+29
+725% +$18.1K 0.01% 327
2021
Q3 		$2K Buy
+4
New +$2.19K ﹤0.01% 389

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Addison Advisors's TMO Position: Q2 2026 in Review

Addison Advisors reduced its Thermo Fisher Scientific (TMO) stake by 24% in Q2 2026, selling an estimated $35.5K and leaving 240 shares worth $120K. The position accounts for 0.06% of the portfolio, ranked #162.

Addison Advisors first reported a position in TMO in Q3 2021 and has held it in 20 quarters since. The position peaked at $197K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Addison Advisors held 240 shares of Thermo Fisher Scientific worth $120K as of Q2 2026.
  • Addison Advisors sold 74 Thermo Fisher Scientific shares in Q2 2026, an estimated $35.5K.
  • Thermo Fisher Scientific made up 0.06% of Addison Advisors's portfolio in Q2 2026, its #162 holding.
  • Addison Advisors first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 20 quarters since.
  • Addison Advisors's Thermo Fisher Scientific position peaked at $197K in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.